መነሻ › ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ › Ohio › Cincinnati
በCincinnati፣ OH ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ 14 ጥናቶች በCincinnati እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- እና 3 ተጨማሪ
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Oncology Hematology Care Clinical Trials, Llc, Cincinnati
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Saint Elizabeth Healthcare ( Site 0041), Edgewood · 8 ማይል ርቀት
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Oncology Hematology Care Inc, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Cincinnati Medical Center, Cincinnati
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati, Cincinnati
- Oncology Hematology Care, Fairfield · 15 ማይል ርቀት
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Cincinnati Medical Center, Cincinnati
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 ማይል ርቀት
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati, Cincinnati
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati, Cincinnati
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Cincinnati Medical Center, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Cincinnati, Cincinnati
በሌሎች ከተሞች ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ጥናቶች
- Boston, MA31 ጥናቶች
- Columbus, OH28 ጥናቶች
- Durham, NC27 ጥናቶች
- Washington, DC22 ጥናቶች
- Seattle, WA20 ጥናቶች
- Rochester, MN19 ጥናቶች
- New York City, NY18 ጥናቶች
- Houston, TX17 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Milwaukee, WI15 ጥናቶች
- Chicago, IL14 ጥናቶች
- Nashville, TN13 ጥናቶች
በCincinnati ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር35 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)27 ጥናቶች
- የጡንቻ ካንሰር25 ጥናቶች
- የልብ ድካም24 ጥናቶች
- የኮሎሬክታል ካንሰር21 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ20 ጥናቶች
- Metastatic Cancer20 ጥናቶች
- የእንቁላል ካንሰር19 ጥናቶች
- የሳንባ ካንሰር19 ጥናቶች
- ከባድ ሰውነት19 ጥናቶች
- የፕሮስቴት ካንሰር18 ጥናቶች
- Multiple Myeloma17 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።